Safety Profile of the Adjuvanted Recombinant Zoster Vaccine in Immunocompromised Populations: An Overview of Six Trials

INTRODUCTION: The adjuvanted recombinant zoster vaccine (RZV) has demonstrated high efficacy against herpes zoster in older adults and immunocompromised populations. We present comprehensive safety data from six clinical trials in immunocompromised populations (autologous hematopoietic stem cell tra...

Descripción completa

Detalles Bibliográficos
Autores principales: López-Fauqued, Marta, Co-van der Mee, Maribel, Bastidas, Adriana, Beukelaers, Pierre, Dagnew, Alemnew F., Fernandez Garcia, Juan Jose, Schuind, Anne, Tavares-da-Silva, Fernanda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8217041/
https://www.ncbi.nlm.nih.gov/pubmed/34115324
http://dx.doi.org/10.1007/s40264-021-01076-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8217041/
https://www.ncbi.nlm.nih.gov/pubmed/34115324
http://dx.doi.org/10.1007/s40264-021-01076-w

Ejemplares similares